Publications by authors named "Weining Robieson"

Claim this Profile
U
Using AI-generated digital twins to boost clinical trial efficiency in Alzheimer's disease.
Deli Wang, Hana Florian, Shau-Yu Lynch, Weining Robieson, Run Zhuang

Alzheimers Dement (N Y)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7-17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies.
Daniel T Radecki, Weining Z Robieson, Mallika Gopalkrishnan, Edward Greenberg, Mohamed Aziz

J Child Adolesc Psychopharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Jason Aldred, Eric Freire-Alvarez, Alexander V Amelin, Angelo Antonini, Bruno Bergmans, Weining Z Robieson

Neurol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Jason Aldred, Eric Freire-Alvarez, Alexander V Amelin, Angelo Antonini, Bruno Bergmans, Weining Z Robieson

Neurol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision making in clinical trials: Interim analyses, innovative design, and biomarkers.
Kathleen A Welsh-Bohmer, Geoffrey A Kerchner, Shobha Dhadda, Miguel Garcia, David S Miller, Weining Robieson

Alzheimers Dement (N Y)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial.
Michael J Soileau, Jason Aldred, Kumar Budur, Nahome Fisseha, Victor Sc Fung, Weining Z Robieson

Lancet Neurol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study.
Sun Ju Chung, Matilde Calopa, Maria G Ceravolo, Nicola Tambasco, Angelo Antonini, Weining Z Robieson

Parkinsons Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified reference based imputation and tipping point analysis in the presence of missing data due to COVID-19.
Man Jin, Ran Liu, Weining Robieson

Contemp Clin Trials· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease.
David G Standaert, Jason Aldred, Marieta Anca-Herschkovitsch, Paul Bourgeois, Esther Cubo, Weining Z Robieson

Mov Disord Clin Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE.
Jason Aldred, Marieta Anca-Herschkovitsch, Angelo Antonini, Ovidiu Bajenaru, Lars Bergmann, Weining Robieson

Neurodegener Dis Manag· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety.
Werner Poewe, Lars Bergmann, Pavnit Kukreja, Weining Z Robieson, Angelo Antonini

J Parkinsons Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Response for "Off" Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry.
Werner Poewe, Lars Bergmann, Weining Z Robieson, Angelo Antonini

Front Neurol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of Levodopa.
Cindy Zadikoff, Werner Poewe, James T Boyd, Lars Bergmann, Horia Ijacu, Weining Z Robieson

Parkinsons Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons Learned From Multi-regional Trials With Signals of Treatment Effect Heterogeneity.
Gang Li, Hui Quan, Gordon Lan, Soo Peter Ouyang, Fei Chen, Weining Robieson

Ther Innov Regul Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies.
James T Boyd, Cindy Zadikoff, Janet A Benesh, Jorge Zamudio, Weining Z Robieson

Clin Park Relat Disord· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical considerations in a delayed-start design to demonstrate disease modification effect in neurodegenerative disorders.
Deli Wang, Weining Robieson, Jun Zhao, Catherine Wiener, Gary Koch

Pharm Stat· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
Hubert H Fernandez, James T Boyd, Victor S C Fung, Mark F Lew, Ramon L Rodriguez, Weining Z Robieson

Mov Disord· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's disease.
Angelo Antonini, Weining Z Robieson, Lars Bergmann, Ashley Yegin, Werner Poewe

Neurodegener Dis Manag· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson's disease.
Miho Murata, Masahito Mihara, Kazuko Hasegawa, Beomseok Jeon, Chon-Haw Tsai, Weining Z Robieson

Ther Adv Neurol Disord· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics.
David G Standaert, James T Boyd, Per Odin, Weining Z Robieson, Jorge Zamudio

NPJ Parkinsons Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.
Hana Florian, Andreas Meier, Serge Gauthier, Stanley Lipschitz, Yunzhi Lin, Weining Z Robieson

J Alzheimers Dis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of levodopa-carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson's disease patients.
Miho Murata, Masahito Mihara, Kazuko Hasegawa, Beomseok Jeon, Chon-Haw Tsai, Weining Z Robieson

NPJ Parkinsons Dis· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
Laura M Gault, Robert A Lenz, Craig W Ritchie, Andreas Meier, Ahmed A Othman, Weining Z Robieson

Alzheimers Res Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's disease.
Hubert H Fernandez, Weining Z Robieson, Krai Chatamra, Jordan Dubow, Susan Eaton

NPJ Parkinsons Dis· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease.
Michael Epstein, David A Johnson, Robert Hawes, Nathan Schmulewitz, Arvydas D Vanagunas, Weining Z Robieson

Clin Transl Gastroenterol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis